Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients

The aim of this study was to evaluate the role of WT1 expression after allogeneic stem cell transplantation (alloHSCT) in patients with acute myeloid leukemia (AML). We studied WT1 expression in bone marrow cells from 50 patients in complete remission on day +60 after transplant. WT1 was assessed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiusolo, Patrizia, Metafuni, Elisabetta, Minnella, Gessica, Giammarco, Sabrina, Bellesi, Silvia, Rossi, Monica, Sorà, Federica, Limongiello, Maria Assunta, Frioni, Filippo, Piccirillo, Nicola, Bianchi, Maria, Valentini, Caterina Giovanna, Teofili, Luciana, Sica, Simona, Bacigalupo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471009/
https://www.ncbi.nlm.nih.gov/pubmed/36119469
http://dx.doi.org/10.3389/fonc.2022.994366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471009/
https://www.ncbi.nlm.nih.gov/pubmed/36119469
http://dx.doi.org/10.3389/fonc.2022.994366

Ejemplares similares